Verified peer comparison
Cabot vs Alnylam Pharmaceuticals Financial Comparison
Direct answer
Cabot and Alnylam Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Cabot email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Cabot Revenue
- 3,713,000,000 USD
- Alnylam Pharmaceuticals Revenue
- 3,713,937,000 USD
- Cabot Operating income
- 621,000,000 USD
- Alnylam Pharmaceuticals Operating income
- 501,578,000 USD